Operating Income: The income after operating expenses.
Biorestorative Therapies, Inc. (BRTX) had Operating Income of $-4.81M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.03M |
|
$-5.34M |
|
$0.00M |
|
$0.02M |
|
$4.83M |
|
|
Operating Income |
$-4.81M |
$-0.53M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$-4.81M |
|
$-4.76M |
|
8.36M |
|
8.36M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$9.36M |
|
$0.37M |
|
$0.97M |
|
$10.33M |
|
$4.18M |
|
-- |
|
-- |
|
$4.18M |
|
$6.13M |
|
$5.54M |
|
$6.14M |
|
7.50M |
|
| Cash Flow Statement Financials | |
$-2.78M |
|
$2.37M |
|
$1.09M |
|
$0.55M |
|
$1.23M |
|
$0.68M |
|
$2.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
88.36% |
|
-19230.13% |
|
-19230.13% |
|
-- |
|
-21359.20% |
|
-21359.20% |
|
$-2.82M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.00 |
|
90.00 |
|
-87.10% |
|
-96.33% |
|
-51.71% |
|
-86.90% |
|
$0.82 |
|
$-0.34 |
|
$-0.33 |
|